Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.6500
-0.0770 (-10.59%)
At close: Jun 18, 2026, 4:00 PM EDT
0.6624
+0.0124 (1.91%)
After-hours: Jun 18, 2026, 7:34 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $4.92 million as of June 18, 2026. Its market cap has decreased by -12.06% in one year.
Market Cap
4.92M
Enterprise Value
-11.33M
1-Year Change
-12.06%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $4.92M, a decrease of -98.08%. That is a compound annual growth rate of -36.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 4.90M | -31.94% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 5.52M |
| Liminatus Pharma | 5.35M |
| Pulmatrix | 5.33M |
| Alaunos Therapeutics | 5.21M |
| CDT Equity | 4.96M |
| CollPlant Biotechnologies | 4.86M |
| Enveric Biosciences | 4.71M |
| Dermata Therapeutics | 4.71M |